The Alliance for Addiction Payment Reform, of which the AHA is a member, is partnering with health care providers and payers to test an alternative payment model for addiction treatment and recovery in Connecticut, Kentucky, North Carolina, Tennessee, Texas and Washington, D.C. The Addiction Recovery Medical Home model aims to reduce health care costs and improve outcomes by addressing a broad continuum of care, from emergent and stabilizing acute-care settings to community-based services and recovery supports.
 
“Nuvance Health is very excited to partner with national thought leaders to redesign how substance use disorders are treated and reimbursed,” said John Murphy, M.D., CEO of Nuvance Health, an AHA member based in Danbury, Conn. “By shifting dollars from the acute care setting to the outpatient setting with linkages into the communities we are able to better serve our population by managing the full continuum of care from prevention to chronic disease management. This approach offers an effective, patient-centered focus for this often-overlooked population.” 
 
The Alliance also plans to pilot the model in additional areas of the country. For more on the model and its episodes of care, visit www.incentivizerecovery.org.

Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
The AHA commented June 1 on the Centers for Medicare & Medicaid Services’ skilled nursing facility prospective payment system proposed rule for fiscal year…
Headline
The AHA submitted comments to the Centers for Medicare & Medicaid Services June 1 on the inpatient psychiatric facility prospective payment system proposed…
Headline
The AHA June 1 urged the Centers for Medicare & Medicaid Services to revisit its market basket forecast and work with Congress to reduce the productivity…
Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…